| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/14/2010 | WO2010004204A2 Fgf-r4 receptor-specific antagonists |
| 01/14/2010 | WO2010003977A1 Therapeutic use of specific ligand in msrv associated diseases |
| 01/14/2010 | WO2010003635A1 Modulation of the immune response by means of the nkp65 receptor and the clec2a ligand thereof |
| 01/14/2010 | WO2010003529A1 Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| 01/14/2010 | WO2010003230A1 Monoclonal antibodies developed to clostridium botulinum flagellin proteins: novel detection reagents |
| 01/14/2010 | WO2009143067A3 Methods, devices, kits and compositions for detecting whipworm |
| 01/14/2010 | WO2009140754A8 An anti-cancer cytotoxic monoclonal antibody |
| 01/14/2010 | WO2009130575A3 Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof |
| 01/14/2010 | WO2009104100A3 Antibody combinations, and methods of making and using same |
| 01/14/2010 | WO2009103969A8 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 01/14/2010 | WO2009094148A3 Ron antibodies and uses thereof |
| 01/14/2010 | WO2008157379A8 Covalent diabodies and uses thereof |
| 01/14/2010 | WO2006014505A9 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/14/2010 | WO2005097421A9 Methods for identifying risk of osteoarthritis and treatments thereof |
| 01/14/2010 | WO2003064603A9 Nucleic acid molecule encoding iwu-1 |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100011452 Chimeric non-human animal |
| 01/14/2010 | US20100010211 Vaccine |
| 01/14/2010 | US20100010210 Vaccine |
| 01/14/2010 | US20100010203 Anti-hydroxylase antibodies and uses thereof |
| 01/14/2010 | US20100010202 Human antibodies derived from immunized xenomice |
| 01/14/2010 | US20100010201 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010199 Making influenza virus vaccines without using eggs |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100009920 Ttk as tumor marker and therapeutic target for lung cancer |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100009869 Antibody libraries |
| 01/14/2010 | US20100009857 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/14/2010 | US20100009463 Reagents for the detection of protein phosphorylation in signaling pathways |
| 01/14/2010 | US20100009452 Functional Peptide Having Activity of Stimulating Immune Cell |
| 01/14/2010 | US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS |
| 01/14/2010 | US20100009438 Dendritic cell potentiation |
| 01/14/2010 | US20100009437 Isolated proteins MAGE-4 and MAGE-41 |
| 01/14/2010 | US20100009410 Methods and Constructs for Expressing Polypeptide Multimers in Eukaryotic Cells Using Alternative Splicing |
| 01/14/2010 | US20100009406 Gene sequence coding formyl peptide receptor binding protein; diagnosing cancer, wound bone healing, obesity, acute heart failure, hypotension, hypertension, urinary retention, osteoporosis, restenosis, atherosclerosis, thrombosis, cardiovascular, autoimmune and nervous system disorders |
| 01/14/2010 | US20100009393 Factor h polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration |
| 01/14/2010 | US20100009390 Mutant antibodies with high affinity for egfr |
| 01/14/2010 | US20100009384 Acyltransferase -1 (ACTR-1); for identifying modulators or are useful themselves as compositions for diagnosis and treatment of disease or disorder that arise from malfunction of the regulation of triacylglycerol (triglyceride) and phospholipid biosynthesis e.g. atherosclerosis; cardiovascular disorders |
| 01/14/2010 | US20100009366 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 01/14/2010 | US20100009345 Compositions and methods comprising a ligand of chemerin R |
| 01/14/2010 | US20100008946 Microorganisms for therapy |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008933 Methods For Treating Obesity By Administering A TRKB Antagonist |
| 01/14/2010 | US20100008929 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 01/14/2010 | US20100008928 Agent for preventing/treating cancer |
| 01/14/2010 | US20100008926 Novel proteins and use thereof |
| 01/14/2010 | US20100008925 Methods and compositions for treatment of endotoxin-mediated pro-inflammatory responses |
| 01/14/2010 | US20100008924 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/14/2010 | US20100008922 In Vivo Induced Genes of Mycobacterium Tuberculosis |
| 01/14/2010 | US20100008921 Diagnostic and Therapeutic Target Adarb2 Proteins for Neurodegenerative Diseases |
| 01/14/2010 | US20100008909 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 01/14/2010 | US20100008908 Treatment of Heart Failure |
| 01/14/2010 | US20100008906 Cripto binding molecules |
| 01/14/2010 | US20100008905 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 01/14/2010 | US20100008902 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof |
| 01/14/2010 | US20100008901 Methods for the treatment and prevention of cancer |
| 01/14/2010 | US20100008888 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 01/14/2010 | US20100008857 Novel hexatriene-beta-carbonyl compound |
| 01/14/2010 | US20100008855 Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies |
| 01/14/2010 | US20100008853 Anti ganglioside gd3 antibodies and uses thereof |
| 01/14/2010 | US20100008851 Anti-gd2 antibodies and methods and uses related thereto |
| 01/14/2010 | DE102008029688A1 Determining and identifying variant of Clostridium difficile strain in sample, comprises obtaining sample, contacting sample with antibody, detecting antibody reaction, comparing obtained reaction pattern with reference and correlating |
| 01/14/2010 | CA2730408A1 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2010 | CA2730300A1 Fgf-r4 receptor-specific antagonists |
| 01/14/2010 | CA2730268A1 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 01/14/2010 | CA2730243A1 Surface display of whole antibodies in eukaryotes |
| 01/14/2010 | CA2730201A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | CA2730073A1 Method of promoting neurogenesis |
| 01/14/2010 | CA2729961A1 Compositions comprising antibodies to lingo or fragments thereof |
| 01/14/2010 | CA2729949A1 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
| 01/14/2010 | CA2729869A1 Therapeutic use of specific ligand in msrv associated diseases |
| 01/14/2010 | CA2729602A1 Notch1 receptor binding agents and methods of use thereof |
| 01/14/2010 | CA2729306A1 Notch-binding agents and antagonists and methods of use thereof |
| 01/14/2010 | CA2729181A1 Constructs and libraries comprising antibody surrogate kappa light chain sequences |
| 01/14/2010 | CA2728909A1 Prostaglandin e2 binding proteins and uses thereof |
| 01/14/2010 | CA2728347A1 Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using same |
| 01/13/2010 | EP2143795A2 Anti-CD20 monoclonal antibody |
| 01/13/2010 | EP2143735A1 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 01/13/2010 | EP2143734A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
| 01/13/2010 | EP2143733A1 ANTI-IL-20 antibodies and binding partners and methods of using in inflammation |
| 01/13/2010 | EP2143732A1 T1R1 Taste receptors and genes encoding same |
| 01/13/2010 | EP2143731A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 01/13/2010 | EP2143438A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143437A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2142645A2 Use of an mmp28 inhibitor for increasing myelination |
| 01/13/2010 | EP2142570A2 Anti-epcam antibody and uses thereof |
| 01/13/2010 | EP2142569A2 Non-fucosylated antibodies |
| 01/13/2010 | EP2142568A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/13/2010 | EP2142567A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 01/13/2010 | EP2142566A1 Methods and compositions for the treatment of proliferative diseases |
| 01/13/2010 | EP2142565A1 Crystalline anti-human il-12 antibodies |
| 01/13/2010 | EP2142213A2 Method of inhibiting complement activation with human anti-factor c3 antibodies and use thereof |
| 01/13/2010 | EP2142210A1 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 01/13/2010 | EP1629011B1 Human anti-human cd3 binding molecules |
| 01/13/2010 | EP1558749B1 Atypical protein kinase c isoforms in disorders of the nervous system and cancer |
| 01/13/2010 | EP1394253B1 Anti-human ovarian cancer -anti-cd3 bispecific antibody |
| 01/13/2010 | EP1117802B1 Nucleic acid molecules which code a branching enzyme from bacteria of the genus neisseria, and a method for producing alpha-1,6-branched alpha-1,4-glucans |
| 01/13/2010 | CN101627055A Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |